Somnomed Limited

 ASX:SOM ISIN:AU000000SOM1

Sep 23, 2014

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH


 

Somnomed Limited Company Summary

 SomnoMed (ASX:SOM) is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent(R) becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent(R) is the most comfortable and effective design and treatment solution for over 130,000 patients in 22 countries. For additional information, visit SomnoMed at http://www.somnomed.com.au
 

PRESENTATIONS

 
 
 

COMPANY DATA

 
Company Principal Sector Health & Pharm 
Company Principal Industry Healthcare 
Company Homepage www.somnomed.com
 

Key Developments: Somnomed Limited
 SomnoMed Limited (ASX:SOM) Announces Half Year Financial Report for 31 December 2013
FEB 26, 2014 09:44 - Article Views: 1,000
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today its results for the first half year to December 2013. The company posted strong unit and revenue growth, generated profits and cash whilst continuing to invest in its future through its medical initiative and further acquisitions in both Europe and the APAC regions.
 SomnoMed (ASX:SOM) Expands in Korea with SomnoDent(R) for Treatment of Obstructive Sleep Apnea
OCT 18, 2013 11:28 - Article Views: 2,048
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.
 Australian Market Report of February 9, 2011: SomnoMed (ASX:SOM) To Benefit From New Medicare Policy In US
FEB 9, 2011 13:30 - Article Views: 5,353
Australian Market Report of February 9, 2011 includes: SomnoMed Limited (ASX:SOM) announced that oral appliance treatment is now reimbursable for Medicare patients in the US; Padbury Mining Limited (ASX:PDY) discovered high-grade haematite mineralisation in Western Australia; Highlands Pacific Limited (ASX:HIG) today reports a 79% increase in resource tonnage at its Frieda Horse Ivaal Trukai project in Papua New Guinea; Zenith Minerals Limited (ASX:ZNC) announced results from Mount Alexander Magnetite Iron Project.

42,949 COMPANY PROFILE VIEWS

 
This Page Viewed: (Last 7 Days: 37) (Last 30 Days: 154) (Since Published: 4236) 
 

Site Search

 
 ENGLISH   All Languages

View in Other Languages

          

MARKETS

 

 ASX S&P200
ASX:SOM
Delayed Data:
Chart by Google

Company Reports

Somnomed Limited (ASX:SOM) Investor Webinar

ABN Newswire on iPhone/iPad

Download from Apple

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile